Ticker Details
Harrow Health, Inc. Common Stock
IPO Date:	October 1, 2007
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$1.54B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.54 | 3.10%
Avg Daily Range (30 D):	$1.22 | 2.97%
Avg Daily Range (90 D):	$1.10 | 2.83%

Institutional Daily Volume
Avg Daily Volume:	.32M
Avg Daily Volume (30 D):	.48M
Avg Daily Volume (90 D):	.65M

Trade Size
Avg Trade Size (Sh.):	70
Avg Trade Size (Sh.) (30 D):	50
Avg Trade Size (Sh.) (90 D):	58

Institutional Trades
Total Institutional Trades:	1,039
Avg Institutional Trade:	$1.86M
Avg Institutional Trade (30 D):	$2.05M
Avg Institutional Trade (90 D):	$2.25M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.13M
Avg Closing Trade (30 D):	$2.47M
Avg Closing Trade (90 D):	$2.74M
Avg Closing Volume:	70.76K

News

Jul 20, 2026 @ 11:00 AM Harrow Highlights Growing Clinical Evidence Suppor... Source: Na

Jun 10, 2026 @ 11:00 AM Harrow Re-Launches VERKAZIA® (cyclosporine opht... Source: Na

May 27, 2026 @ 11:00 AM Harrow to Present at William Blair’s 46th A... Source: Na

Mar 24, 2026 @ 8:57 PM Harrow Announces Pricing of $50.0 Million Offering... Source: Na

Mar 24, 2026 @ 1:18 PM A Major Investor Just Sold $7.8 Million in Harrow ... Source: Andy Gould

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.46	$-.74	$.18
Diluted EPS	$-.46	$-.74	$.18
Revenue	$70.66M	$44.2M	$89.09M
Gross Profit	$50.36M	$27.05M	$70.62M
Net Income / Loss	$-17.27M	$-27.6M	$6.63M
Operating Income / Loss	$-11.01M	$-22.08M	$15.59M
Cost of Revenue	$20.3M	$17.16M	$18.47M
Net Cash Flow	$-10.76M	$21.72M	$-1.36M
PE Ratio

Splits
Feb 08, 2013	1:5